Literature DB >> 4989673

Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data.

W H Traub.   

Abstract

Seventy-eight of 420 clinical isolates of Pseudomonas aeruginosa yielded zones of inhibition of less than 12 mm in diameter around 10-mug discs of gentamicin sulfate when tested by the standardized Bauer-Kirby disc diffusion method. Of 153 strains chosen from these isolates, one strain (0.65%) required 25 mug of gentamicin per ml for inhibition; the remainder (99.35%) were inhibited by 6 mug/ml or less of the antibiotic. It is recommended that those isolates of P. aeruginosa that yield zones of inhibition less than 12 mm in diameter be disc susceptibility-tested once more; those isolates that give zones of inhibition of less than 12 mm upon repeated examination should then be subjected to the broth dilution test before they are designated as sensitive or resistant to gentamicin.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4989673      PMCID: PMC376874          DOI: 10.1128/am.20.1.98-102.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors:  R J BULGER; S SIDELL; W M KIRBY
Journal:  Ann Intern Med       Date:  1963-11       Impact factor: 25.391

2.  LABORATORY STUDIES ON GENTAMICIN.

Authors:  M RUBENIS; V M KOZIJ; G G JACKSON
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

3.  Recent microbiological studies with gentamicin.

Authors:  J A Waitz; M J Weinstein
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

4.  [Studies on the effectiveness of gentamicin against gram-negative rod-shaped bacteria].

Authors:  J Sander; C Blasius
Journal:  Dtsch Med Wochenschr       Date:  1968-07-19       Impact factor: 0.628

5.  Gentamicin: in vitro studies.

Authors:  W M Kirby; H C Standiford
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  In vitro susceptibility of gram-negative bacilli to gentamicin.

Authors:  J A Washington; R E Ritts; W J Martin
Journal:  Mayo Clin Proc       Date:  1970-02       Impact factor: 7.616

8.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

  8 in total
  12 in total

1.  Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.

Authors:  I B Duncan
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

2.  Transfer of R-factor mediated aminoglycoside antibiotic resistance in the allantoic cavity of chick embryos.

Authors:  W H Traub; M E Craddock
Journal:  Experientia       Date:  1971-08

3.  In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.

Authors:  M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

4.  Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection.

Authors:  W H Traub; M E Craddock; E A Raymond; M Fox; C E McCall
Journal:  Appl Microbiol       Date:  1971-09

5.  Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.

Authors:  V E Del Bene; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

6.  In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.

Authors:  R D Meyer; L L Draus; K A Pasieczinik
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Interpretation of diffusion susceptibility data obtained with 50-mu g carbenicillin discs against gram-negative organisms.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1971-11

8.  Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1972-01

9.  Pharmacokinetic properties of netilmicin in newborn infants.

Authors:  J D Siegel; G H McCracken; M L Thomas; N Threlkeld
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

10.  Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.

Authors:  W R Lockwood; L A Lawson
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.